GSK369796 – (1010411-21-8)

SAR125844, 1116743-46-4, SAR-125844, UNII-XH93U6NIJE, SAR 125844, XH93U6NIJE, 1-(6-((6-(4-fluorophenyl)-[1, 2, 4]triazolo[4, 3-b]pyridazin-3-yl)thio)benzo[d]thiazol-2-yl)-3-(2-morpholinoethyl)urea, Urea, N-[6-[[6-(4-fluorophenyl)-1, 2, 4-triazolo[4, 3-b]pyridazin-3-yl]thio]-2-benzothiazolyl]-N'-[2-(4-morpholinyl)ethyl]-, CHEMBL4461070, 1-(6-((6-(4-Fluorophenyl)(1, 2, 4)triazolo(4, 3-b)pyridazin-3-yl)sulfanyl)-1, 3-benzothiazol-2-yl)-3-(2-(morpholin-4-yl)ethyl)urea, Urea, N-(6-((6-(4-fluorophenyl)-1, 2, 4-triazolo(4, 3-b)pyridazin-3-yl)thio)-2-benzothiazolyl)-N'-(2-(4-morpholinyl)ethyl)-, 1-[6-[[6-(4-fluorophenyl)-[1, 2, 4]triazolo[4, 3-b]pyridazin-3-yl]sulfanyl]-1, 3-benzothiazol-2-yl]-3-(2-morpholin-4-ylethyl)urea, 3-(6-{[6-(4-fluorophenyl)-[1, 2, 4]triazolo[4, 3-b]pyridazin-3-yl]sulfanyl}-1, 3-benzothiazol-2-yl)-1-[2-(morpholin-4-yl)ethyl]urea, 1-(6-{[6-(4-Fluorophenyl)[1, 2, 4]triazolo[4, 3-B]pyridazin-3-Yl]sulfanyl}-1, 3-Benzothiazol-2-Yl)-3-[2-(Morpholin-4-Yl)ethyl]urea, 3-(6-((6-(4-fluorophenyl)-(1, 2, 4)triazolo(4, 3-b)pyridazin-3-yl)sulfanyl)-1, 3-benzothiazol-2-yl)-1-(2-(morpholin-4-yl)ethyl)urea, SCHEMBL2801192, ODIUNTQOXRXOIV-UHFFFAOYSA-N, DTXSID901031348, BCP28183, EX-A2198, RUB74346, BDBM50532757, NSC771652, s7564, SAR125884, AKOS032954063, DB15382, NSC-771652, SAR125844?, SB16715, AC-35976, BS-14459, DA-57657, HY-16446, MET Tyrosine Kinase Inhibitor SAR125844, CS-0006341, N17079, SAR 125844 SAR-125844, 1-(6-(6-(4-fluorophenyl)-(1, 2, 4)triazolo(4, 3-b)pyridazin-3-ylsulfanyl)benzothiazol-2-yl)-3-(2-morpholin-4-ylethyl)urea, 1-(6-{[6-(4-fluorophenyl)[1, 2, 4]triazolo[4, 3-b]pyridazin-3-yl]sulphanyl}-1, 3-benzothiazol-2-yl)-3-(2-morpholin-4-ylethyl)urea, 1-(6-{[6-(4-fluorophenyl)[1, 2, 4]triazolo[4, 3-b]pyridazin-3-yl]sulphanyl}-1, 3-benzothiazol-2-yl)-3-[2-(morpholin-4-yl)ethyl]urea